Effects of high-density lipoprotein and the apoprotein of high-density lipoprotein on prostacyclin synthesis by endothelial cells.
D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis*; D000818:Animals; D001053:Apolipoproteins / Q000097:blood / Q000494:pharmacology*; D001054:Apolipoproteins A; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D004727:Endothelium / Q000187:drug effects / Q000378:metabolism*; D011464:Epoprostenol / Q000096:biosynthesis*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008075:Lipoproteins, HDL / Q000097:blood / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*; D013552:Swine
D001053:Apolipoproteins; D001054:Apolipoproteins A; D001095:Arachidonic Acids; D008075:Lipoproteins, HDL; D011453:Prostaglandins; D016718:Arachidonic Acid; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol; D007213:Indomethacin